Loading data
HRTXNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Cost of revenue | 41.35 m USD | 38.65 m USD | 65.11 m USD | 54.87 m USD | 46.02 m USD |
| Gross profit | 113.56 m USD | 105.64 m USD | 61.94 m USD | 52.8 m USD | — |
| Research and development expense | 12.43 m USD | 16.68 m USD | 39.13 m USD | 82.7 m USD | 130.82 m USD |
| Operating profit | -2.54 m USD | -11.53 m USD | -110.62 m USD | -174.66 m USD | -217.83 m USD |
| Interest expense | — | — | 3.87 m USD | 2.47 m USD | 2.41 m USD |
| Income tax expense | 0 USD | 0 USD | 0 USD | 0 USD | 0 USD |
| Net income (reported basis) | -20 m USD | -14 m USD | -111 m USD | -182 m USD | -221 m USD |
| Basic earnings per share | -0.12 USD/share | -0.09 USD/share | -0.8 USD/share | -1.67 USD/share | -2.24 USD/share |
| Diluted earnings per share | -0.12 USD/share | -0.09 USD/share | -0.8 USD/share | -1.67 USD/share | -2.24 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.